1. Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, Kokocinski F,
et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res 2012;22:1760–1774.
2. Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT,
et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 2007;316:1484–1488.
3. Hajjari M, Salavaty A. HOTAIR: an oncogenic long non-coding RNA in different cancers. Cancer Biol Med 2015;12:1–9.
4. Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet 2014;15:7–21.
5. Yu X, Li Z. Long non-coding RNA
HOTAIR: a novel oncogene (review). Mol Med Rep 2015;12:5611–5618.
6. Khandelwal A, Malhotra A, Jain M, Vasquez KM, Jain A. The emerging role of long non-coding RNA in gallbladder cancer pathogenesis. Biochimie 2017;132:152–160.
8. Mercer TR, Mattick JS. Structure and function of long non-coding RNAs in epigenetic regulation. Nat Struct Mol Biol 2013;20:300–307.
9. Li CH, Chen Y. Targeting long non-coding RNAs in cancers: progress and prospects. Int J Biochem Cell Biol 2013;45:1895–1910.
10. Ishibashi M, Kogo R, Shibata K, Sawada G, Takahashi Y, Kurashige J,
et al. Clinical significance of the expression of long non-coding RNA
HOTAIR in primary hepatocellular carcinoma. Oncol Rep 2013;29:946–950.
11. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA,
et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007;129:1311–1323.
12. Loewen G, Zhuo Y, Zhuang Y, Jayawickramarajah J, Shan B. lincRNA
HOTAIR as a novel promoter of cancer progression. J Can Res Updates 2014;3:134–140.
13. Bhan A, Mandal SS. Estradiol-induced transcriptional regulation of long non-coding RNA,
HOTAIR
. Methods Mol Biol 2016;1366:395–412.
14. He S, Liu S, Zhu H. The sequence, structure and evolutionary features of
HOTAIR in mammals. BMC Evol Biol 2011;11:102.
15. Zhang J, Zhang P, Wang L, Piao HL, Ma L. Long non-coding RNA
HOTAIR in carcinogenesis and metastasis. Acta Biochim Biophys Sin (Shanghai) 2014;46:1–5.
16. Schorderet P, Duboule D. Structural and functional differences in the long non-coding RNA
hotair in mouse and human. PLoS Genet 2011;7:e1002071.
17. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F,
et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010;329:689–693.
18. Meredith EK, Balas MM, Sindy K, Haislop K, Johnson AM. An RNA matchmaker protein regulates the activity of the long noncoding RNA
HOTAIR
. RNA 2016;22:995–1010.
19. Ma MZ, Li CX, Zhang Y, Weng MZ, Zhang MD, Qin YY,
et al. Long non-coding RNA
HOTAIR, a c-Myc activated driver of malignancy, negatively regulates miRNA-130a in gallbladder cancer. Mol Cancer 2014;13:156.
20. Wu Y, Zhang L, Wang Y, Li H, Ren X, Wei F,
et al. Long non-coding RNA
HOTAIR involvement in cancer. Tumour Biol 2014;35:9531–9538.
21. Berrondo C, Flax J, Kucherov V, Siebert A, Osinski T, Rosenberg A,
et al. Expression of the long non-coding RNA
HOTAIR correlates with disease progression in bladder cancer and is contained in bladder cancer patient urinary exosomes. PLoS One 2016;11:e0147236.
22. Kim HJ, Lee DW, Yim GW, Nam EJ, Kim S, Kim SW,
et al. Long non-coding RNA
HOTAIR is associated with human cervical cancer progression. Int J Oncol 2015;46:521–530.
23. Li J, Yang S, Su N, Wang Y, Yu J, Qiu H,
et al. Overexpression of long non-coding RNA
HOTAIR leads to chemoresistance by activating the Wnt/beta-catenin pathway in human ovarian cancer. Tumour Biol 2016;37:2057–2065.
24. Chiyomaru T, Fukuhara S, Saini S, Majid S, Deng G, Shahryari V,
et al. Long non-coding RNA
HOTAIR is targeted and regulated by miR-141 in human cancer cells. J Biol Chem 2014;289:12550–12565.
25. Guo W, Dong Z, Bai Y, Guo Y, Shen S, Kuang G,
et al. Associations between polymorphisms of
HOTAIR and risk of gastric cardia adenocarcinoma in a population of north China. Tumour Biol 2015;36:2845–2854.
27. Pedersen AG, Baldi P, Brunak S, Chauvin Y. Characterization of prokaryotic and eukaryotic promoters using hidden Markov models. Proc Int Conf Intell Syst Mol Biol 1996;4:182–191.
28. Prestridge DS. Predicting Pol II promoter sequences using transcription factor binding sites. J Mol Biol 1995;249:923–932.
30. Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol 1987;196:261–282.
31. Boucher CA, King SK, Carey N, Krahe R, Winchester CL, Rahman S,
et al. A novel homeodomain-encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable (CTG)n repeat. Hum Mol Genet 1995;4:1919–1925.
33. Hajjari M, Khoshnevisan A, Lemos B. Characterizing the retinoblastoma 1 locus: putative elements for Rb1 regulation by
in silico analysis. Front Genet 2014;5:2.
35. Wang Z, Fan H, Yang HH, Hu Y, Buetow KH, Lee MP. Comparative sequence analysis of imprinted genes between human and mouse to reveal imprinting signatures. Genomics 2004;83:395–401.
36. Hajjari M, Behmanesh M, Jahani MM.
In silico finding of putative cis-acting elements for the tethering of polycomb repressive complex 2 in human genome. Bioinformation 2014;10:187–190.
38. Jeziorska DM, Jordan KW, Vance KW. A systems biology approach to understanding cis-regulatory module function. Semin Cell Dev Biol 2009;20:856–862.
41. Suzuki H, Maruyama R, Yamamoto E, Niinuma T, Kai M. Relationship between noncoding RNA dysregulation and epigenetic mechanisms in cancer. The Long and Short Non-coding RNAs in Cancer Biology. (Song E, ed.). Singapore: Springer, 2016. pp. 109–135.
42. Deng J, Yang M, Jiang R, An N, Wang X, Liu B. Long non-coding RNA
HOTAIR regulates the proliferation, self-renewal capacity, tumor formation and migration of the cancer stem-like cell (CSC) subpopulation enriched from breast cancer cells. PLoS One 2017;12:e0170860.
43. Kim K, Jutooru I, Chadalapaka G, Johnson G, Frank J, Burghardt R,
et al.
HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 2013;32:1616–1625.
44. Nakagawa T, Endo H, Yokoyama M, Abe J, Tamai K, Tanaka N,
et al. Large noncoding RNA
HOTAIR enhances aggressive biological behavior and is associated with short disease-free survival in human non-small cell lung cancer. Biochem Biophys Res Commun 2013;436:319–324.
45. Borley J, Brown R. Epigenetic mechanisms and therapeutic targets of chemotherapy resistance in epithelial ovarian cancer. Ann Med 2015;47:359–369.
46. Loewen G, Jayawickramarajah J, Zhuo Y, Shan B. Functions of lncRNA
HOTAIR in lung cancer. J Hematol Oncol 2014;7:90.
47. Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 2012;13:484–492.
48. Pan W, Liu L, Wei J, Ge Y, Zhang J, Chen H,
et al. A functional lncRNA
HOTAIR genetic variant contributes to gastric cancer susceptibility. Mol Carcinog 2016;55:90–96.
49. Du M, Wang W, Jin H, Wang Q, Ge Y, Lu J,
et al. The association analysis of lncRNA
HOTAIR genetic variants and gastric cancer risk in a Chinese population. Oncotarget 2015;6:31255–31262.
50. Xue Y, Gu D, Ma G, Zhu L, Hua Q, Chu H,
et al. Genetic variants in lncRNA
HOTAIR are associated with risk of colorectal cancer. Mutagenesis 2015;30:303–310.
51. Yan R, Cao J, Song C, Chen Y, Wu Z, Wang K,
et al. Polymorphisms in lncRNA
HOTAIR and susceptibility to breast cancer in a Chinese population. Cancer Epidemiol 2015;39:978–985.
52. Wu H, Shang X, Shi Y, Yang Z, Zhao J, Yang M,
et al. Genetic variants of lncRNA
HOTAIR and risk of epithelial ovarian cancer among Chinese women. Oncotarget 2016;7:41047–41052.